Anika Therapeutics ANIK
NASDAQ ANIK
$19.75 -0.20 (-1.00%)
As of: Sep 30, 2026 · 1:00 PM EDT

Anika Therapeutics, Inc. (ANIK) EV to EBIT (2011 - 2024)

Updated

Anika Therapeutics' (ANIK) EV to EBIT came in at 13.41 for Q3 2024, down 39.0% from the prior quarter.

Analysis

Anika Therapeutics, Inc. (ANIK) EV to EBIT (2011 - 2024) Analysis & Trends

For the trailing twelve months through Sep 30, 2024, EV to EBIT at Anika Therapeutics was -0.99; for FY2023, it was 280.92, up 230.5% from FY2022.

  • In prior years, Anika Therapeutics' EV to EBIT was 85.00 in FY2022 (-43.5%), 150.36 in FY2021 and 16.26 in FY2019 (+11.0%).
  • The Q3 2024 figure stands as the lowest quarterly EV to EBIT since Q1 2020.
  • According to Business Quant data, EV to EBIT for the three prior quarters was 21.97 (Q2 2024), 25.32 (Q1 2024) and 280.92 (Q4 2023).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 13.41
Jun 30, 2024 21.97
Mar 31, 2024 25.32
Dec 31, 2023 280.92
Dec 31, 2022 85.00
Dec 31, 2021 150.36
Jun 30, 2020 27.17
Mar 31, 2020 8.87
Dec 31, 2019 16.26
Sep 30, 2019 15.56
Jun 30, 2019 11.71
Mar 31, 2019 7.50
Dec 31, 2018 14.65
Sep 30, 2018 20.74
Jun 30, 2018 13.98
Mar 31, 2018 19.07
Dec 31, 2017 13.88
Sep 30, 2017 14.31
Jun 30, 2017 11.13
Mar 31, 2017 10.40
API Access

Anika Therapeutics, Inc. EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ANIK&period=max&api_key=YOUR_API_KEY